spacer
home > news
INDUSTRY NEWS AND PRESS RELEASES
 

Turkish Cargo received the Customer Satisfaction Management Certificate (ISO 10002).

Turkish Cargo, the fastest growing air cargo brand in the world, obtained the "Customer Satisfaction Management Certificate" (ISO 10002) and developed the Cargo Customers Feedback Management Policy accordingly. More>>

 
phone +90 212 463 63 63
web www.turkishcargo.com.tr/en
 

3P Biopharmaceuticals initiates partnership with American Biotech Zhittya for Parkinson’s disease treatment

[Pamplona, 21 October, 2019] 3P Biopharmaceuticals (3P), a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, and the American biotech company, Zhittya Genesis Medici

3P and Zhittya began their relationship at the beginning of 2019 with 3P being selected as the CDMO to transfer the process for scaling up and performing cGMP manufacturing for clinical studies. After successfully achieving transfer of the process, 3P anticipates manufacturing of the first cGMP batch by the second quarter of 2020. More>>

 
phone +34 948 34 64 80
web www.3pbio.com/
email Polígono Mocholí, Plaza Cein, 1, 31110 Noáin, Navarra
 

Merck Launches ADC ExpressTM Services to Accelerate Pre-clinical Conjugation Candidate Selection

• Provides rapid production of antibody drug conjugates (ADCs) for best candidate selection • Established platform technology to reliably scale target molecules • Reduces time to clinic through comprehensive ADC services from pre-clinical to commercial from a single source More>>

 
phone +33 (0)5 57 960 960
email Sebastien.ribault@merckgroup.com
web www.merckmillipore.com/adaptive-CDMO
email 1 rue Jacques Monod, Site Montesquieu, 33650 Martillac, France
 

Signant Health Proudly Sponsors “DISORDER: The Rare Disease Film Festival” to Raise Awareness and Hope for Millions of Families Worldwide

DISORDER brings a creative and uniquely personalized advocacy forum to San Francisco on November 9-10 in San Francisco

PHILADELPHIA, PA –September 30, 2019: There are 7,000 recognized rare disease conditions that affect between 25 and 30 million people in the United States alone, and the vast majority are totally unknown in the community. What if there was a film to bring each of these diseases, and the people fighting them, into the spotlight? More>>

 
phone +1 267 498 2300
email media@signanthealth.com
web https://signanthealth.com/
email 4000 Chemical Road Suite 300 Plymouth Meeting, PA 19462
 

CPhI Pharmaceutical Machinery Report: ‘critical time to invest in machinery with changing drugs pipeline’

Report predicts tomorrow’s biggest industry winners will need to invest now ahead of the curve

Ahead of P-MEC 2019, the only dedicated pharmaceutical machinery event in Europe this year – co-located with CPhI Worldwide in Frankfurt, 5-7 November – the first ever CPhI Pharmaceutical Machinery Report identifies trends impacting the market. More>>

 
phone +31 (0)20 708 1637
email cphicustomerservice@ubm.com
web www.cphi.com
email Delhi, India
 

Discussing developments on Highly Potent APIs with industry expert, Richard Arnett for the HPAPI USA conference 2019

SMI Reports: Exclusive interview with industry expert, Richard Arnett Manager, Industrial Hygiene, Pharmascience for the HPAPI USA conference 2019

Ahead of the 2019 HPAPI USA Conference taking place in Boston on 21st – 22nd October, SMi caught up with Richard Arnett, Manager, Industrial Hygiene, Pharmascience who is speaking on Day Two of the agenda. Richard shared his thoughts on how the industry has developed and briefly touched on what he will be discussing in October. More>>

 
phone +44 (0)20 7827 6000
email events@smi-online.co.uk
web https://smi-online.co.uk/
email London
 

A new market reference added to Safe’n’Sound®, our passive safety device platform

Safe’n’Sound® is on the market in Europe with a newly registered injectable medication. The commercial launch of HULIO™ (Adalimumab Biosimilar) was initiated in selected European markets on October 19,2018. Hulio™, developed by Fujifilm Kyowa Kirin Biologics Co., Ltd. and marketed in the European Union by Mylan N.V. is approved as a biosimilar for the same indications as the reference product, Humira®. More>>

 
phone +33 4 74 94 06 54
email information@nemera.net
web www.nemera.net
email 20 avenue de la Gare, 38290 – La Verpillière, France
 

Huge boom in Korean Pharma reported at CPhI Korea

Event sees new Memorandum of Understanding signed by PROLMED and KPTA

Amsterdam, 19th September 2019: The recently-closed CPhI Korea – co-organised by Informa Markets and the Korea Pharmaceutical Traders Association (KPTA) – has seen a surge in growth across domestic and international pharma companies, as well as a sizable rise in overall attendees. As reported earlier this year in the provisional findings of the CPhI Pharma Index[1], Korea has seen a rapid growth in its international reputation (seeing its ‘overall competitiveness’ rise 14% in the last two years), which is now translating into a sizable growth in the market and at the event. More>>

 
web https://www.cphi.com/korea/
email Hall C COEX, Seoul
 

3P Biopharmaceuticals receives FDA approval

The FDA classified 3P facilities as acceptable for the manufacture of the target molecule, and appropriate for its commercialization in the US market, once the product is authorized

[Pamplona, September 16th, 2019] 3P Biopharmaceuticals (3P), a leading Contract Development and Manufacturing Organisation (CDMO) specialized in process development and GMP manufacturing of biologics, receives FDA approval after completing the Pre-Approval Inspection (PAI) conducted at the 3P drug substance manufacturing facility. More>>

 
web https://www.3pbio.com/
 

IATA CEIV Pharma certificate of Turkish Cargo renewed

Turkish Cargo, the air cargo brand flying to the most countries around the world, extended the validity period of its IATA CEIV (Center of Excellence for Independent Validators) Pharma certificate to 2022, proving its success in all processes throughout the air transportation of medicinal products. More>>

 
phone +90 212 463 63 63
web www.turkishcargo.com.tr/en
 
 
spacer
News and Press Releases

CPI to showcase results from BioStreamline project developing novel biotherapeutics

CPI, a UK-based technology innovation centre and a founding member of the High Value Manufacturing Catapult, announced today that it will host an event in Darlington, UK on 26 June 2019 to disseminate the results of the £11.2M BioStreamline project to optimise the development of novel therapeutics. During the event, the project partners — Lonza Biologics, UCB Celltech, Sphere Fluidics, Horizon Discovery Group plc (Horizon), Alcyomics Ltd and CPI — will showcase the results and discuss the potential impact on overcoming some of the most significant shortcomings of the biologics supply chain.
More info >>


White Papers

Life Cycle of an Analytical Method - a Case Study on the Monocyte Activation Test

Wickham Laboratories Limited

Pyrogens, a heterogeneous group of fever inducing contaminants, are comprised of microbial and non-microbial compounds; e.g. endotoxin (lipopolysaccharide, LPS) produced by Gram-negative bacteria, lipoteichoic acid (LTA) from Gram-positive bacteria, bacterial DNA (CpG-motive), endogenous pyrogens, virus and fungi particles or even fragments of packaging materials, plastic and dust. Contaminat ion wi th pyrogens in pharmaceutical products, biotherapeutics and on medical devices can lead to life threatening fever reactions. To ensure consumer safety, pyrogen testing is mandatory for parenteral products and medical devices.
More info >>

Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement